Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User ...
Tags: Takeda Pharmaceutical Company Limited, Prescription Drug User Fee Act
Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation AMITYVILLE, N.Y., December 26, 2013--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today announced that the Texas Attorney General has agreed to ...
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
Biodel, a specialty pharmaceutical company, has announced a long-term supply agreement with Becton, Dickinson and Company, a medical technology company, for worldwide exclusive rights to the novel and proprietary BD Uniject SCF disposable ...
Tags: Biodel, Rescue Device
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...
Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations
Unilife, a medical device and technology company, has announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the ...
Tags: Unilife, medical device
Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...
Dietary supplements are dominating the shelves of pharmacy retailers, with brands vying for the attention of health-conscious consumers. In fact, industry experts report that approximately 50% of American adults take dietary supplements. ...
Tags: Light Industry, Daily Use
QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...
Tags: QRxPharma, Drug Application
France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Chicken and oc may seem like an obvious pairing to culinary enthusiasts, but at least one Pennsylvania farm is demonstrating its extraordinary health benefits in food production as well. For three years or so, chickens at Bell & Evans have ...
Tags: chicken, farmer, oregano oil, cinnamon, antibiotics
Intellipharmaceutics International has announced that the US Food and Drug Administration (FDA) has granted final approval of the company's dexmethylphenidate hydrochloride extended-release capsules for the 15 and 30mg strengths. ...
Tags: Focalin XR, Medicine
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Novartis, a Swiss multinational pharmaceutical company, has signed a definitive agreement to divest its blood transfusion diagnostics unit to Spanish company Grifols for $1.675bn. The blood transfusion diagnostics unit became part of ...
Tags: Novartis, blood transfusion
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE: 002422) revealed the decision to suspend equity acquisition in Lijun International Pharmaceutical (Holding) Co., Ltd. (SEHK: 2005). Earlier, the intended buyer has inked agreement with Prime ...